<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is a unique B-cell non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with 3 established clinical-epidemiological variants: endemic, <z:hpo ids='HP_0003745'>sporadic</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> variants show characteristic dysregulation of MYC gene, but the causes of MYC dysregulation or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> arising at different ages are poorly understood </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we examined population-based <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> incidence patterns in the United States to determine age-related risk </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> case and population data were obtained from the NCI's Surveillance, Epidemiology and End Results Databases (1973-2005) </plain></SENT>
<SENT sid="4" pm="."><plain>Standard cross-sectional age-standardized and age-specific incidence rates were stratified by sex and race and supplemented with age-period-cohort models </plain></SENT>
<SENT sid="5" pm="."><plain>We analyzed 3,058 BL cases diagnosed during 1,160,300,297 person-years of observation </plain></SENT>
<SENT sid="6" pm="."><plain>Age-standardized incidence rates rose 6.8% per year (95% CI 4.5-9.1) for males and 7.1% (95% CI 3.2-11.1) for females during the study period </plain></SENT>
<SENT sid="7" pm="."><plain>The rate among males was 3.2 times that among females, and among Whites 1.3 times that among Blacks </plain></SENT>
<SENT sid="8" pm="."><plain>Male-to-female incidence rate ratios did not differ by race, but were 4.2 for pediatric (0-19 years), 4.1 for adult (20-59 years) and 2.0 for geriatric (&gt; or = 60 years) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Cross-sectional age-specific rates showed 2 separate peaks among males and females, near ages 10 and 75 years, and a 3rd peak near age 40 years among males </plain></SENT>
<SENT sid="10" pm="."><plain>The tri/bimodal incidence pattern was present in sensitivity analyses excluding registries with many HIV/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> cases and in period-specific, cohort-specific analyses </plain></SENT>
<SENT sid="11" pm="."><plain>To our knowledge, tri/bimodal incidence patterns have not previously been reported for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Trimodal/bimodal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> suggests <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in etiology or biology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> diagnosed at different ages in males and females </plain></SENT>
</text></document>